Nearly 3 million Americans suffer from treatment-resistant depression, meaning antidepressants simply don’t work for them. Motif Neurotech wants to change that with a tiny brain implant, and the FDA has just greenlighted a human trial to test it.
As reported by Wired, the Houston-based startup has developed a tiny device that sits in the skull, just above the brain’s protective membrane. It targets the part of the brain responsible for high-level thinking that tends to go quiet in people with major depressive disorder. The implant delivers precise electrical pulses to wake that network back up.
Recommended Videos
The best part? The whole procedure takes only 20 minutes and doesn’t require traditional brain surgery.
So how does this actually work?
Once implanted, the device is powered wirelessly. Patients charge and control it using a baseball cap that sends stimulation data directly to the implant. You wear the cap
...Keep reading this article on Digital Trends.
